Eli Lilly & Co. bumped up its offer for Bothell's Icos Corp. on Monday by 6 percent after a proxy firm and others advised shareholders to vote against an earlier offer. Lilly originally offered $32 ...
Icos Corp., the largest publicly traded biotechnology company in the Seattle area and the developer of the erectile dysfunction drug Cialis, has agreed to be acquired for $2.1 billion in cash by its ...
BOSTON (MarketWatch) -- Eli Lilly & Co. has increased its bid for Icos Corp. by more than 6% to a "final offer" of $34 a share, translating into a total value of about $2.3 billion, the suitor said ...
Alongside the rise of Bitcoin and other cryptocurrencies, Initial Coin Offerings (ICOs) saw explosive growth in 2017, with more than 1,500 ICOs raising a combined total of over $28 billion in the last ...
Eli Lilly has agreed to purchase ICOS, co-marketer of erectile dysfunction drug Cialis (tadalfil), for approximately $2.1 billion. Lilly and ICOS have been partners in Cialis since 1998 and launched ...
After an acrimonious three-month takeover battle, it took barely 12 minutes Thursday to bring the curtain down on Bothell-based Icos. Investors holding about two-thirds of Icos’ stock voted to sell ...
Hosted on MSN
Finally, a gaming chair that does things differently – but I’m not sure I can stomach the cost
The Quersus ICOS.2 is a striking gaming chair with a few unique features that help it stand out even more in the homogeneous gaming chair space. The slender frame and sharp angles certainly look ...
ICOs are at the source of a lot of noise and discussion in the blockchain and cryptocurrency industry. The Blockchain Conference by Beyond Blocks, held earlier this month in Bangkok brought to light ...
Eli Lilly and Co. will gain full ownership of the impotence treatment Cialis with a $2.1 billion acquisition of joint venture partner Icos Corp., the companies announced Tuesday. Lilly will pay $32 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback